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Oxytocin neurons have a physiological role in food intake and energy balance. Central
administration of oxytocin is powerfully anorexigenic, reducing food intake and meal dura-
tion.The central mechanisms underlying this effect of oxytocin have become better under-
stood in the past few years. Parvocellular neurons of the paraventricular nucleus project
to the caudal brainstem to regulate feeding via autonomic functions including the gas-
trointestinal vago-vagal reflex. In contrast, magnocellular neurons of the supraoptic and
paraventricular nuclei release oxytocin from their dendrites to diffuse to distant hypothala-
mic targets involved in satiety. The ventromedial hypothalamus, for example, expresses a
high density of oxytocin receptors but does not contain detectable oxytocin nerve fibers.
Magnocellular neurons represent targets for the anorexigenic neuropeptide α-melanocyte
stimulating hormone. In addition to homeostatic control, oxytocin may also have a role in
reward-related feeding. Evidence suggests that oxytocin can selectively suppress sugar
intake and that it may have a role in limiting the intake of palatable food by inhibiting the
reward pathway.
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INTRODUCTION
Unlike Roald Dahl’s “enormously fat” Augustus Gloop – a boy
who pursued eating as a hobby – humans usually eat much less
than they could. Obesity is typically the result of a modest excess
of energy intake over expenditure, but one that is sustained over a
prolonged period. In fact, humans, like other animals, are very effi-
cient at balancing energy intake and expenditure. If rats are allowed
unlimited access to a high-energy palatable diet, their energy intake
diverges quickly from control animals fed a bland diet, but the dif-
ference in energy intake stabilizes within days (Archer and Mercer,
2007). Thus rats, which presumably do not feel societal pressure
to be slim, will overeat palatable food, but only to a certain extent.
When their access to palatable food ends, rats typically undereat,
failing to defend the extra body weight they have accumulated.
A variety of peripheral signals convey information to con-
trol meal size and, in the longer term, these signals are modified
according to physiological state and the size of energy reserves.
Several “satiety” peptides are secreted from the gastrointestinal
tract, including cholecystokinin (CCK), glucagon-like-peptide-1
(GLP-1), and peptide YY (PYY) (Strader and Woods, 2005); some
of these act on the brain at sites that lack a blood-brain barrier,
others are transported across the blood-brain barrier, and oth-
ers act via vagal neuronal afferents (Verbalis et al., 1986). Leptin,
which is secreted from adipose tissue in proportion to the size of
fat stores, is not itself a satiety signal, but by signaling the size of
peripheral fat reserves it has a long term anorectic influence, and
in part it may act by moderating acute satiety signals arising from
the gastrointestinal tract. Whether these satiety signals and leptin
all converge at a discrete “satiety center” in the brain is unclear
but several neuronal populations have been identified as likely
candidates for mediating satiety. In part, these have been identi-
fied because they synthesize peptides that have marked anorexic
actions when administered centrally.
One of those potently anorectic neuropeptides is oxytocin – a
peptide classically thought to be involved mainly in reproductive
functions. However, as we review here, there is now considerable
evidence that oxytocin also plays an important role in satiety.
PHYSIOLOGICAL ROLES OF OXYTOCIN
Oxytocin is produced in two hypothalamic regions: the supraoptic
nucleus (SON) and paraventricular nucleus (PVN). Magnocellu-
lar neuroendocrine neurons in these nuclei project to the posterior
pituitary gland, from where oxytocin is secreted into the blood.
Classically, oxytocin secreted from the pituitary gland is involved
in efficient and timely fetal expulsion, and is indispensable for
the milk-ejection reflex and successful lactation (Nishimori et al.,
1996); in some species, including rodents but not humans, it also
regulates sodium excretion (natriuresis) (Verbalis et al., 1991),
both by direct actions at the kidneys and indirectly be regulat-
ing the secretion of natriuretic peptides from the heart (McCann
et al., 2003); in these species it is secreted in response to raised
plasma osmotic pressure (Huang et al., 1996). All of the oxytocin
neurons in the SON are magnocellular neuroendocrine neurons,
but the PVN also contains parvocellular oxytocin neurons that
project within the brain – to the spinal cord, caudal brainstem,
amygdala, and substantia nigra (Sofroniew, 1980). These neurons
are important in sexual behavior in males (Melis et al., 1986), and,
as we discuss below, in the regulation of gastric reflexes.
Recently it has become apparent that oxytocin has an important
“pro-social” role. In rodents, it has been implicated in recogni-
tion and positive social behavior between rodent mothers and
their offspring and between adult members of the same social
group (Neumann, 2009). However, behaviors linked to oxytocin
are not all positive. In the rat, for example, patterns of central
oxytocin release correlate with maternal aggression against unfa-
miliar intruders (Bosch et al., 2005). Various “social” effects of
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oxytocin in humans have also been reported, but mainly following
the intranasal administration of doses of oxytocin so large that it
is hard to be confident of where or how they are acting.
It is unclear to what extent these “behavioral” roles of oxy-
tocin are attributable to the parvocellular oxytocin system or the
magnocellular system, because many of the sites of action of
oxytocin in this regard lack conspicuous innervation by oxytocin-
containing fibers. Accordingly, it seems likely that oxytocin reaches
these sites by volume transmission following release from possibly
quite distant sites. Large amounts of oxytocin are released in some
circumstances from the dendrites of magnocellular neurons (Lud-
wig and Leng, 2006), and interestingly, such dendritic released is
regulated independently of axonal secretion – thus magnocellu-
lar neurons can release oxytocin either centrally or peripherally
depending upon the stimulus (Sabatier et al., 2003).
OXYTOCIN AND FOOD INTAKE
In early studies of hypothalamic function, lesions of oxytocin-
containing hypothalamic nuclei were shown to result in an increase
in food intake and body weight (Leibowitz et al., 1981; Shor-Posner
et al., 1985; Sims and Lorden, 1986; Kirchgessner et al., 1988).
Then, in the 1990s, several studies reported anorexigenic effects of
central oxytocin: low doses of oxytocin given icv dose-dependently
inhibited food intake in rats, increased the latency to begin feeding
and reduced meal duration in both hungry and satiated animals,
and these actions could be blocked by oxytocin receptor antago-
nists (Arletti et al., 1990; Olson et al., 1991a). Longer term central
infusions of oxytocin were also reported to reduce body weight
gain in rats given a high-fat diet, but in contrast to oxytocin’s acute
effects, chronic oxytocin infusions did not alter total food intake
or meal patterning, but instead appeared to stimulate lipid metab-
olism in adipose tissue (Deblon et al., 2011). It was noted that, in
rats, dehydration or sodium loading potently increased oxytocin
secretion and at the same time suppressed appetite (Flanagan et al.,
1992a); given that (in rats) oxytocin promotes natriuresis (Verbalis
et al., 1991), the suppression of appetite by oxytocin appeared to
be part of a general homeostatic role in sodium balance. As oxy-
tocin secretion is not stimulated by hyperosmolarity in humans
(Williams et al., 1986) it seemed that this role of oxytocin might
be one peculiar to rodents. However, recent findings in humans
with rare genetic mutations linked to monogenic obesity indi-
cate that oxytocin may also have a role in appetite regulation in
humans.
Male (but not female) oxytocin receptor-deficient mice express
an obese phenotype in later adulthood despite no difference in
food intake or motor activity (Takayanagi et al., 2008). Male and
female oxytocin-knockout mice show an elevation in body weight
and fat stores in adulthood but as with oxytocin receptor-deficient
mice this is not due to an increase in food intake (Nishimori et al.,
1996). There have been no published reports of humans com-
pletely lacking either oxytocin or its receptor, probably because
the absence of oxytocin or its receptor is incompatible with suc-
cessful reproduction, but a partial deficiency in central oxytocin
production has been associated with the development of obesity
in humans in two documented conditions.
The transcription factor Single-minded 1 (Sim1) is one of the
few genes associated with human monogenic obesity (Holder et al.,
2000; Farooqi and O’Rahilly, 2005). In mice, Sim1 is expressed in
the SON and PVN and is essential for the development of these
nuclei (Michaud et al., 1998). Homozygous Sim1 knockout mice
do not survive gestation; but heterozygous mice are viable and are
hyperphagic and become obese early in life (Michaud et al., 2001).
These mice have much-reduced levels of oxytocin mRNA and
immunoreactive oxytocin in both the SON and PVN (Michaud
et al., 2001), and their hyperphagia can be reversed by oxytocin
given icv (Kublaoui et al., 2008). Conditional deletion of Sim1
after gestational development of the PVN also results in both a
reduction in oxytocin mRNA expression, and in hyperphagia and
obesity (Tolson et al., 2010). In contrast, mice overexpressing Sim1
do not increase their food intake when given a high-fat diet, and
are resistant to diet-induced obesity (Kublaoui et al., 2006b).
Patients affected by Prader–Willi syndrome (PWS) caused by
the lack of a segment in the paternal chromosome 15 suffer from
morbid obesity due to extreme hyperphagia. The PVN of these
patients contains fewer oxytocin neurons than controls (Swaab
et al., 1995), leading to speculation that a deficiency in oxytocin
may be instrumental in the development of obesity in this con-
dition. Mice in which specific genes associated with the PWS
syndrome have been knocked out similarly develop late-onset
obesity due to hyperphagia, and this can be partly explained by
a deficient production of oxytocin in the hypothalamus (Dombret
et al., 2012) or by a reduction in the number of oxytocin neurons
(Muscatelli et al., 2000).
WHERE DOES APPETITE-INHIBITORY OXYTOCIN COME
FROM?
In the last 20 years it has become apparent that oxytocin neurons
in both the SON and PVN are powerfully regulated by appetite-
related signals (Renaud et al., 1987; Olson et al., 1991a,b). The
role of central oxytocin in the regulation of energy homeostasis
appears to involve both the magnocellular neurons and centrally
projecting parvocellular neurons.
PARVOCELLULAR NEURONS OF THE PVN
The PVN has a major role in the regulation of appetite and
metabolism, and is an important direct target of projections from
the primary leptin- and ghrelin-receptive neurons of the arcuate
nucleus – from orexigenic neurons that co-express neuropeptide Y
(NPY) and agouti-related peptide (AgRP) and the inhibitory neu-
rotransmitter GABA, and from pro-opiomelanocortin (POMC)-
containing neurons, which express the potent satiety peptides
α-melanocyte stimulating hormone (α-MSH) and cocaine-and
amphetamine regulating transcript (CART) (Valassi et al., 2008).
The PVN regulates metabolism via neuroendocrine neurons that
release thyrotropin releasing hormone to regulate the thyroid
gland (Alkemade, 2010; Nillni, 2010), it regulates glucocorticoid
production via its regulation of pituitary adrenocorticotropin
secretion (Herman et al., 2003), and it regulates the sympathetic
nervous system via a large population of pre-autonomic neurons
(Ferguson et al., 2008; Kc and Dick, 2010). However, the oxytocin
neurons in the PVN, like those in the SON, are also conspicuous
targets for α-MSH (Kim et al., 2000), and are particularly pow-
erfully influenced by food intake and a variety of nutritionally
related signals.
Frontiers in Endocrinology | Neuroendocrine Science March 2013 | Volume 4 | Article 35 | 2
Sabatier et al. Oxytocin and satiety
In rats, the expression of oxytocin mRNA in the PVN is
markedly reduced by fasting; this reduction can be reversed by
leptin administration (Kublaoui et al., 2008) and these effects
apparently involve both magnocellular neurons and parvocellu-
lar neurons. Oxytocin neurons in the PVN are also contacted by
fibers arising from the NPY/AgRP/GABA neurons of the arcuate
nucleus. The PVN expresses abundant GABA receptors (Kalsbeek
et al., 2004) and NPY Y1 receptors (Yokosuka et al., 1999). Opto-
genetic activation of the GABAergic axons in the PVN that arise
from the arcuate nucleus increases food intake. Similarly, direct
optogenetic activation of PVN oxytocin neurons increases c-Fos
expression in these neurons and suppresses food intake. In the
same study, a pharmacogenetic approach showed that while acute
silencing of arcuate POMC neurons has surprisingly little effect,
silencing Sim1-expressing PVN neurons markedly increases food
intake (Atasoy et al., 2012).
Many parvocellular oxytocin neurons project to the nucleus
tractus solitarii (NTS) in the caudal brainstem (Rinaman, 1998)
where oxytocin modulates vagal efferent pathways that regulate
gastric motility (McCann and Rogers, 1990). These neurons are
critically involved in a reflex that is triggered by food intake, and
mediated in part by gastric distension and in part by the secretion
of CCK from the duodenum. Peripheral administration of CCK
leads to activation of gastric vagal afferent neurons and thence to
activation of brainstem structures, notably the NTS and ventro-
lateral medulla (Simpson et al., 2012). These in turn project to,
and activate, centrally projecting oxytocin neurons of the PVN.
As the CCK-stimulated NTS neurons are densely innervated by
oxytocin-containing fibers from the PVN (Blevins et al., 2003),
it appears that there is a recurrent circuit involving parvocellular
oxytocin neurons that modulates the gastrointestinal vago-vagal
reflex.
The gastrointestinal vago-vagal reflex involves main three-
components: the gastrointestinal tract, the NTS, and the dorsal
motor nucleus of the vagus (DMV). Visceral afferent fibers car-
rying digestion-related information ascend the vagus nerve and
terminate in the medial NTS. NTS neurons integrate the informa-
tion and send afferent projections to the DMV, and DMV neurons
in turn project back down to the intrinsic ganglia in the gastroin-
testinal tract. In addition to this main loop, catecholaminergic
and peptidergic neurons of the NTS also send ascending projec-
tions to structures in the forebrain including the PVN and the
SON, and parvocellular PVN neurons project back to both the
NTS and the DMN (Saper et al., 1976; Swanson and Kuypers,
1980). There is clear evidence that oxytocin acts in the DMN
to inhibit gastric motility: the DMN contains oxytocin receptors
(Dubois-Dauphin et al., 1992) and injection of oxytocin into the
DMN decreases gastric motility, while oxytocin antagonists have
the opposite effect (Rogers and Hermann, 1987). Electrical stim-
ulation of the PVN inhibits gastric motility, and this effect can
be attenuated by injection of an oxytocin antagonist in the DMN
(Rogers and Hermann, 1987). Similar results were observed in
conscious, freely moving animals, in which gastric motility was
reduced by icv injection of oxytocin and by stimulation of the
PVN, and in both cases the inhibition was prevented by icv injec-
tion of an oxytocin antagonist (Flanagan et al., 1992b). Finally, icv
administration of an oxytocin antagonist alone increased baseline
gastric motility, suggesting a tonic inhibitory effect of oxytocin
on gastric motility. However, it seems unlikely that the inhibitory
action of CCK on gastric motility is mediated by oxytocin, as icv
injection of an oxytocin antagonist did not prevent CCK-induced
inhibition of gastric motility (Flanagan et al., 1992b).
Thus there is a well-established role of parvocellular oxytocin
neurons in the regulation of the gastrointestinal tract. Moreover,
the magnocellular oxytocin neurons of the SON and PVN also
appear to be involved in regulating appetite, possibly by the actions
of dendritically released oxytocin on the ventromedial nucleus of
the hypothalamus (VMN). This large nucleus is known to have an
important role in both energy balance and sexual behavior, and is
a site at which oxytocin receptors are expressed at an exception-
ally high density (Tribollet et al., 1988) as well as insulin-regulated
aminopeptidase (IRAP), an enzyme involved in the inactivation
of oxytocin (Fernando et al., 2005).
MAGNOCELLULAR NEURONS OF THE SON AND PVN
As we discuss further below, there is powerful evidence that mag-
nocellular oxytocin neurons have an important role in the regula-
tion of appetite – but it is important to note that this role is not
necessarily mediated by oxytocin alone. In magnocellular neurons
of the SON and PVN, oxytocin is co-localized with a number of
anorexigenic factors, including the neuropeptides CART (Vrang
et al., 1999), pituitary adenylate cyclase activating polypeptide
(PACAP) (Koves et al., 1994), corticotropin-releasing factor (CRF)
(Sawchenko et al., 1984), CCK (Vanderhaeghen et al., 1981), and
nesfatin-1 (Foo et al., 2008). Indeed, it has been suggested that oxy-
tocin actually mediates the inhibitory action of nesfatin-1 on food
intake, as nesfatin-1 induces the release of oxytocin in the PVN
(Maejima et al., 2009) and as the anorexigenic effect of nesfatin-1
can be blocked by an oxytocin antagonist (Yosten and Samson,
2010). The fat mass and obesity-associated (FTO) gene that has
been associated with obesity in humans is also co-localized with
oxytocin in both the PVN and SON. This gene encodes a tran-
scription co-factor (Fto) that is believed to regulate the expression
of appetite-related genes (Jia et al., 2008), and Fto over-expression
increases oxytocin mRNA levels in cell cultures (Olszewski et al.,
2011).
Magnocellular oxytocin neurons are activated during feeding:
thus, in schedule-fed rats trained to expect to receive food for
just 2 h each day, magnocellular oxytocin neurons in both the
SON and PVN densely express Fos protein soon after the initi-
ation of food intake (Johnstone et al., 2006). These neurons are
also activated by gastric distension, and by systemic application
of the satiety peptides CCK (Renaud et al., 1987) and GLP-1
(Bojanowska and Stempniak, 2000). Moreover, the intestinal lipid
amide oleoylethanolamide (OEA), which suppresses feeding via
activation of the vagus nerve (Lo Verme et al., 2005), stimulates
oxytocin mRNA expression in the PVN and SON, this anorexic
effect is prevented by blockade of central oxytocin receptors
(Gaetani et al., 2010).
The best understood pathway involving feeding-evoked activa-
tion of magnocellular oxytocin neurons is that where peripheral
injections of CCK leads to secretion of oxytocin from the posterior
pituitary gland in rats. In brief, CCK is released from the duode-
num in response to food intake and peripheral administration
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of CCK can inhibit food intake via stimulation of vagal affer-
ent neurons and activation of brainstem structures, notably the
NTS and ventrolateral medulla. CCK given intraperitoneally or
intravenously increases Fos expression in oxytocin neurons in the
PVN and SON (Caquineau et al., 2010), increases the electrical
activity of oxytocin neurons in the SON (Renaud et al., 1987;
Leng et al., 1991) and increases plasma oxytocin secretion (Kutlu
et al., 2010). These actions are mediated by a direct projection
from noradrenergic neurons of the A2 cell group, which co-express
the potent appetite-inhibiting peptide prolactin-releasing peptide
(PrRP). The activation of oxytocin neurons can be blocked by
selective lesioning of the noradrenergic afferents or by blocking
the actions at the SON of noradrenaline itself or those of PrRP
(Onaka et al., 2012). Interestingly, central pretreatment with an
oxytocin receptor antagonist reduces the anorexigenic effect of
CCK (Olson et al., 1991b; Blevins et al., 2003) suggesting that
CCK-evoked satiety may be mediated in part by oxytocin.
INTERACTIONS BETWEEN MAGNOCELLULAR OXYTOCIN NEURONS
AND THE MELANOCORTINS
Like parvocellular oxytocin neurons, magnocellular oxytocin neu-
rons abundantly express leptin receptors and are a target for this
important hormone (Hakansson et al., 1998; Yarnell et al., 1998;
Brogan et al., 2000). Leptin activates Fos expression in the PVN
(Yokosuka et al., 1998; Caquineau et al., 2010; Qi et al., 2010),
particularly in parvocellular PVN neurons projecting to CCK-
sensitive neurons in the NTS. In the SON, however, central admin-
istration of leptin does not induce Fos expression (Caquineau et al.,
2010) or nuclear translocation of STAT3 (Hakansson and Meister,
1998), but it does increase nuclear STAT5 expression (Mutze et al.,
2007).
In addition to this direct modulation by leptin, magnocellular
oxytocin neurons are regulated indirectly via the effects of leptin
on POMC neurons of the arcuate nucleus. Like the PVN, the SON
receives a strong projection from POMC neurons. Oxytocin neu-
rons in the SON, like those in the PVN, densely express α-MSH
receptors (MC4) (Garza et al., 2008). α-MSH is a powerful anorex-
igenic peptide: centrally administered α-MSH reduces food intake
and body weight, and mice lacking MC4 receptors are hyperphagic
and obese (Adan et al., 2006). As mentioned above, magnocellu-
lar oxytocin neurons can secrete a large amount of peptide from
their dendrites in response to certain stimuli, and notably they
do so in response to α-MSH. In magnocellular oxytocin neu-
rons of the SON, α-MSH acts at MC4 receptors to increase the
intracellular calcium concentration; this increase directly evokes
oxytocin release from the large dendrites of these neurons and also
results in the production of endocannabinoids by the oxytocin
neurons. Endocannabinoids produced in response to α-MSH act
presynaptically to suppress glutamatergic afferent inputs to the
oxytocin neurons. Thus, remarkably, the response of magnocel-
lular oxytocin neurons to α-MSH is an increase in central release
of oxytocin but a simultaneous suppression of electrical activity
and hence a suppression of secretion into the systemic circulation
(Sabatier and Leng, 2006).
Further evidence of an interaction between oxytocin and α-
MSH is illustrated in the model of Sim1 heterozygous mice. In
wild type mice, an agonist of α-MSH MC4 receptor (MC4R)
reduced food intake, and induced Fos expression in PVN neurons,
of which some co-express oxytocin and MC4R (Liu et al., 2003),
and oxytocin and Sim1 (Kublaoui et al., 2008). However in Sim1
heterozygous mice, MC4R agonist had a much attenuated effect on
both food intake and Fos expression in the PVN (Kublaoui et al.,
2006a). This suggests that the α-MSH agonist actions on the PVN
of Sim1± mice were impaired by the lack of oxytocin production
in these mice (Michaud et al., 2001).
THE VENTROMEDIAL NUCLEUS OF THE HYPOTHALAMUS – A SITE OF
ACTION OF OXYTOCIN
It seems possible that oxytocin released from the dendrites of
magnocellular neurons is involved in the regulation of appetite,
presumably reaching its targets by volume transmission. We have
estimated that a release rate of just one vesicle per oxytocin cell
every 10 s would be enough to achieve a mean basal concentra-
tion of∼260 pg/ml throughout the anterior hypothalamus within
a minute (Leng and Ludwig, 2008). The half life of oxytocin in
CSF is ∼20 min – it is likely to be less than this in the extra-
cellular fluid, but there are no clear data on this point. We have
argued elsewhere that the effects of oxytocin depends less on its
sites of release but rather on the location of its receptors (Sabatier
et al., 2007). Thus it is likely that food intake is inhibited in var-
ious physiological conditions in which oxytocin is released from
the dendrites of magnocellular neurons. Indeed, appetite is inhib-
ited in rats subjected to dehydration or sodium loading (Flanagan
et al., 1992a), two stimuli that result in a hyperosmolar environ-
ment, which is known to stimulate the dendritic release of oxytocin
from supraoptic neurons (Neumann et al., 1993). The main physi-
ological circumstances in which there is extensive central secretion
of oxytocin is in lactation, when suckling-induced dendritic oxy-
tocin release is an essential part of the milk-ejection reflex (Rossoni
et al., 2008). Lactation is associated with a marked increase of food
intake, rather than a reduction, but despite this, lactation is a time
of negative energy balance, because the increased food intake does
not adequately compensate for the energy demands of the suck-
ling young. Accordingly, it seems that appetite during lactation is
not increased to the degree needed to maintain energy homeosta-
sis – and it may be that suppression of appetite during suckling is
necessary to ensure that the mother nurses the young rather than
searches for food.
One particularly intriguing potential target for dendritic oxy-
tocin is the VMN. This large hypothalamic nucleus contains a very
high density of oxytocin receptors, as shown by intense labeling
both for oxytocin receptor binding sites (Tribollet et al., 1988)
and oxytocin receptor mRNA expression (Yoshimura et al., 1993),
particularly in the ventrolateral region. Oxytocin receptors in the
VMN have an established role in sexual behavior in female rats
(McCarthy et al., 1994), and we have previously suggested that
they are involved in the reciprocal regulation of appetite and sex-
ual behavior (Leng and Ludwig, 2008). Although the VMN has a
high density of oxytocin receptors, it contains very few oxytocin
fibers, and is therefore a likely target for oxytocin released from the
dendrites of magnocellular oxytocin neurons (Leng and Ludwig,
2008).
The VMN is not a functionally homogeneous nucleus so it is
not surprising that systemic injections of CCK have diverse effects
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on VMN neurons, but the most common effect of CCKon the
electrical activity of VMN neurons is inhibitory (Sabatier and
Leng, 2010); these responses varied particularly between different
subpopulations of VMN that displayed contrasting electrophysi-
ological features. To test whether the appetite-inhibiting effects of
oxytocin and those of CCK converge at the level of the VMN, we
have studied the effects of central icv injection of oxytocin on the
electrical activity of VMN neurons in vivo, and compared these
responses with those of the same neurons to CCK. As with CCK,
the responses to oxytocin were diverse. About 30% of neurons
responded to oxytocin, 78% with a significant increase in their
mean firing rate (Figure 1), and again there were differences in the
responses of electrophysiologically distinct subpopulations. How-
ever, when we compared the responses of the same neurons to CCK
and oxytocin, we noted particularly that, while one subpopulation
of neurons had clearly divergent responses to CCK and oxytocin,
in all other subpopulations the responses were remarkably con-
vergent – for most neuronal types in the VMN, the response to icv
oxytocin was a very strong predictor of the response to systemic
CCK (Figure 2), supporting the hypothesis that VMN neurons are
part of a common pathway mediating satiety.
Finally, to test the feasibility of the hypothesis that oxytocin
affects VMN neurons via dendritic release of oxytocin from
magnocellular neurons, we studied the electrical activity of sin-
gle VMN neurons while applying α-MSH directly to the ipsilateral
SON by microdialysis to evoke dendritic oxytocin release. Like the
effects of icv oxytocin, this too had long-lasting, mainly excitatory
effects upon a subset of VMN neurons (Figure 3).
OXYTOCIN AND REWARD
In addition to the drive to eat for metabolizable energy and nutri-
tional factors (homeostatic feeding), humans and many other
animals attend selectively to palatable foods and are motivated
to eat them for pleasure (hedonic feeding). In addition to its
effects on homeostatic food intake, oxytocin may have a role in
the modulation of hedonic food intake.
Activation of dopaminergic mesolimbic neurons of the ventral
tegmental area (VTA) is currently thought to be closely associ-
ated with reward and motivation. During palatable food intake,
dopamine is released in the VTA’s target regions such as the
nucleus accumbens (NAcc) and dopamine release in these struc-
tures can also be evoked by stimuli associated with or predictive
of palatable food. It is likely that activation of this system equates
with the motivation to attend to, pursue and consume reward-
ing stimuli like palatable food. Oxytocin-containing axons from
the PVN contact mesolimbic neurons (Sofroniew, 1980; Succu
FIGURE 1 | Responses to icv oxytocin inVMN neurons in vivo. Single
VMN neurons were recorded extracellularly from the VMN of
urethane-anesthetized rats (Sabatier and Leng, 2008). (A) Each bar represent
the mean change in firing rate (±SD) averaged over the first 10 min after icv
injection of oxytocin (1–10 ng) in each VMN cell tested. The cells are ranked by
response magnitude and are classed as inhibited, non-responsive, and excited
according to whether the responses were significant or not. (B)
Representative example of an inhibition (left panel) and activation (right panel)
of the mean firing rate in response to icv oxytocin in a single VMN cell
recorded extracellularly. (C) Mean change in firing rate (±SE) in the VMN cells
that were significantly activated ; n=14), significantly inhibited ;
n=4), and not significantly affected ; n=43) by icv oxytocin.
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FIGURE 2 | Correlation of responses to icv oxytocin and iv CCK inVMN
neurons in vivo. (A) Mean change in firing rate (±SE) in response to icv
oxytocin (1–10 ng) in single VMN cells that were activated ; n=5),
inhibited ; n=4), and not affected ; n=6) by iv CCK injection. (B)
Rank correlation of responses to CCK and oxytocin (high ranks excited; low
ranks inhibited). The solid line is the linear fit to the ranks (r 2 =0.65). (C)
Example of convergent responses to icv oxytocin (1–10 ng) and iv CCK
(20µg/kg) in a single VMN neuron.
et al., 2008) and likely have an inhibitory action as exogenous
oxytocin activates NO synthase in mesolimbic dopaminergic neu-
rons in vivo (Succu et al., 2008. Exogenous oxytocin also reduces
amphetamine-evoked dopamine turnover in the NAcc (Qi et al.,
2008) and inhibits the formation of a place-preference to metham-
phetamine when given into the NAcc core (Baracz et al., 2012).
However, administration of oxytocin does not always lead to a
reduction in dopamine release, administration into the ventral
subiculum for example, a hippocampal region innervated by the
PVN and potentially involved in restraining the stress response
and reinstating non-food reward responding behavior, results in
increased dopamine release in the NAcc (Melis et al., 2009). Inhi-
bition of the PVN by optical stimulation of GABAergic fibers from
arcuate NPY/AgRP/GABA neurons increases motivation to obtain
sugar in a progressive ratio lever pressing task (Atasoy et al., 2012)
suggesting that signals arising from the PVN may suppress the
motivation for rewarding foods.
Consumption of readily catabolizable sugars seems to be innate
in animals. Without training, rodents given a choice between water
and sucrose will consume large volumes of a 10% sucrose solution
[over 200 ml a day in adult male Sprague-Dawley rats (unpub-
lished observations)] and voluntarily cease water drinking. Even
transgenic mice lacking functional sweet taste receptors prefer
sucrose over water (de Araujo et al., 2008) indicating that a post-
ingestive reward is provided by sucrose. Transgenic mice lacking
oxytocin show an enhanced preference for and consumption of
sweet solutions over water in a two-bottle choice paradigm (Amico
et al., 2005; Billings et al., 2006). The increase in intake is driven by a
greater number of feeding bouts rather than by an increase in their
duration (Sclafani et al., 2007). However, no such effect of oxytocin
deficiency is seen on consumption of a palatable high-fat liquid
formulation (Miedlar et al., 2007) or of a sucrose-containing solid
food (Amico et al., 2005), though scheduled feeding of a high-
sugar diet to rats increases oxytocin gene expression (Olszewski
et al., 2009). Progressive ratio operant conditioning paradigms are
often used as a measure of motivation to work for a reward. In con-
trast to an effect of oxytocin deficiency on freely available sweet
solutions, there is less evidence that oxytocin-deficient mice have
enhancements (or deficiencies) in motivation to work for food as
they are not different to wild type mice in this task (Sclafani et al.,
2007). In addition to Fos expression observed at the termination
of bland food intake (Johnstone et al., 2006), Fos expression is also
increased in PVN oxytocin neurons at the termination of a bout
of feeding where only either sucrose or a high-fat food was avail-
able (Olszewski et al., 2010). In this study, hypothalamic oxytocin
mRNA levels were higher in mice allowed access to a high-sugar
diet compared to a high-fat diet despite both being palatable and
readily consumed. Furthermore, oxytocin receptor antagonism led
to an increase in sucrose consumption but has no effect on fat con-
sumption when presented separately. Regular exposure in rats to
a diet high in sugar reduces Fos expression in PVN and SON oxy-
tocin neurons after a high- or low-sugar meal compared to animals
regularly receiving a low-sugar diet (Mitra et al., 2010). This sug-
gests that regular sugar consumption might blunt the activity of
oxytocin neurons in response to any meal, whether high in sugar
or not. Nonetheless, it may be that oxytocin has a satiating effect
related to certain components of diet rather than a general effect.
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FIGURE 3 | (A) Magnocellular oxytocin neurons are inhibited by icv
injections of α-MSH and this effect can be blocked by pre-administration
of a CB1 cannabinoid antagonist (Sabatier et al., 2003). (B) Oxytocin
secretion from the posterior pituitary gland is reduced by icv injection of
MC4 agonists. (C) However, α-MSH and MC4 agonists induce Fos
expression in magnocellular oxytocin neurons and (D) induce dendritic
oxytocin release. (E) Application of α-MSH retrodialysis to the SON
affects the electrical activity of VMN neurons in vivo. Mean change in
firing rate (±SE) in VMN neurons that were not affected (open bars;
n=13), and activated (solid bars; n= 8; P <0.005, 0–30 min vs. control)
in the 30 min period from the start of α-MSH infusion (100µM) on the
SON.
Thus, the balance of evidence suggests that oxytocin might have
a role in limiting the intake of palatable food by suppressing the
activation of the reward pathway.
CONCLUSION
It now seems clear that oxytocin has a physiological role in energy
balance through its actions in the caudal brainstem, but probably
also through actions within the hypothalamus, including at the
VMN, and possibly at other sites in the brain. While the actions
in the brainstem appear to be part of a suite of autonomic regula-
tory functions exercised by parvocellular oxytocin neurons of the
PVN, the hypothalamic actions appear to be more associated with
motivational drive to eat, and are probably attributable to the mag-
nocellular oxytocin system rather than the parvocellular system.
It is possible that the inhibitory effects of oxytocin on appetite
are closely linked to the stimulatory effects of oxytocin in sexual
behavior and that this link reflects an evolutionarily conserved rec-
iprocal regulation of these two key motivational drives (Caquineau
et al., 2012). Whether it is possible to find a way of dissociating
the appetite-inhibiting effects of oxytocin from the sexual arousal
effects is unclear at present, but this may be the key to success in
using the oxytocin system as a target for appetite-reducing drug
therapies.
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